ADVERTISEMENT

Pharma Q3 Results Preview - Double-Digit Growth In Revenue; Margins Remain Under Pressure: Nirmal Bang

Growth in domestic formulations is expected to be driven by continued strong growth in the chronic segment.

<div class="paragraphs"><p>Various types of colorful pills arranged for photograph. (Source: freepik)</p></div>
Various types of colorful pills arranged for photograph. (Source: freepik)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit